semaglutide weight loss treatment nevada Medical GLP-1 in (NV) Weight Loss & Metabolic Health

Shauna Levy, a specialist in obesity medicine and the medical director of the Tulane Bariatric Center in New Orleans, referring to the class of drugs that include Wegovy and Zepbound

The results showed significant HbA1c reductions with semaglutide: Semaglutide 0.5 mg: HbA1c reduced by 1.3% Semaglutide 1.0 mg: HbA1c reduced by 1.6% Sitagliptin 100 mg: HbA1c reduced by 0.5% From a baseline HbA1c of 8.1%, semaglutide helped significantly more participants reach target blood sugar levels compared to sitagliptin

The injection is typically administered once a week, while the pill is taken once a day

Wegovy is a prescription injection used for weight loss, to lower risk of cardiovascular problems, and to treat metabolic dysfunction-associated steatohepatitis (MASH)